At a time when over seventy per cent of Africans still lack access to treatments against HIV, malaria and tuberculosis, among other diseases, Cameroon has taken a giant step to develop the production of generic drugs with the help of the African Union. Much less expensive than brand drugs, these drugs will be accessible to a greater number of people at affordable prices.